Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
executive order on artificial intelligence

What they’re saying about the White House’s executive order on AI

In the Biden administration’s latest push to encourage beneficial AI innovation while discouraging hazardous AI risk-taking, the president on Monday announced an executive order fleshing out that coupled call.

Thumbnail

President Biden issues ‘landmark’ executive order on artificial intelligence

The Medical Imaging & Technology Alliance, which represents device manufacturers, praised the president's announcement.

Department of Justice DOJ

Florida woman sentenced in $36M physical therapy fraud

Arisleidys Fernandez Delmas of Florida pleaded guilty for billing physical therapy services that patients never received.

Jesse M. Ehrenfeld

The physician shortage is here: AMA implores Congress to address ‘urgent crisis’

“Physicians everywhere—across every state and specialty—continue to carry tremendous burdens that have us frustrated, burned out, abandoning hope," said AMA President Jesse Ehrenfeld. 

rural healthcare

Is Medicare Advantage kryptonite to rural hospitals?

PLUS: 8 noteworthy developments in rural American healthcare

Ken Rosenfield, MD, Mass General Hospital, explains the impact wider CMS reimbursement for carotid artery stenting will have on patient stroke care and interventional cardiology. CAS

Q&A: Ken Rosenfield explains the impact of new reimbursement coverage for carotid stenting 

Ken Rosenfield, MD, helped spearhead the recent Medicare policy change that made carotid stenting procedures available to more patients.

Thumbnail

Physicians fight to end ban on doc-owned hospitals while AHA advocates for status quo

A proposal to end the moratorium on new POHs was among several policies discussed at a House Energy & Commerce Committee hearing Oct. 19. 

CMS changes coverage policy for carotid stenting to make it more widely available

A group of interventional cardiologists, neurologists and vascular surgeons successfully petitioned Medicare to change its coverage determination for carotid stenting procedures.

Displaying 297 - 304 of 2769

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup